5-Loxin: The Magic component in Osteo Bi-flex5–Loxin is the new component in the realm of joint supplement and has been an essential ingredient in Osteo Bi-flex. It is a patent-pending compound which improves joint comfort and mobility. It also helps reduce the action of harmful enzymes that break down protective joint tissues. While a new ingredient, it is steeped in the historic roots of the Boswellia serrata plant, used in traditional Indian medicine for centuries. Thus, 5-Loxin is the modern approach to tradition and history of Indian herbal therapy, being clinically proven for its effectiveness.
In a recent human study, both 100mg and 250mg of 5-Loxin daily provided improvement in joint comfort and mobility within 7 days. Osteo-Bi-flex is known to work better than most of the joint supplements available and this can be attributed to the efficacy of 5-Loxin.5-Loxin provided significant and sustained benefits in WOMAC, VAS and LFI standardized testing methodologies for joint health and improvement in arthritic conditions.
5-Loxin is well-tolerated by the population, gentle on the stomach and supported by extensive safety data
5-Loxin was shown to significantly inhibit matrix metalloproteinase (MMP-3), enzymes that break down cartilage, collagen and connective tissues
5-Loxin positively impacted biological markers associated with joint and general health, including TNFa, CRP, and IL-6
Published research supports 5-Loxin's targeted and precise function, efficacy and safety in laboratory and human studies. In addition to promoting joint health, 5-Loxin has been shown to protect joint tissues by helping regulate the action of harmful enzymes that break down cartilage.
5-Loxin is a new joint health ingredient that has been researched and awarded in India and Australia, with patents pending in North America. Its usage has been deeply rooted in the ancient history of Boswellia serrata extracts. The Boswellia tree has been used for thousands of years in traditional Ayurvedic medicine in India, and recent studies have shown that modern extracts may provide powerful benefits in promoting joint comfort, knee mobility and improvement in walking distance.
Laila Nutra, the inventors of 5-Loxin, identified the most powerful Boswellia compound called 3-0-acetyl-11-keto-beta boswellic acid (AKBA), and developed a method to produce an extract that provides 30% AKBA, a composition ten times more concentrated than common Boswellia extracts. This is largely responsible for astounding success of Osteo Bi-flex in the domain of joint care supplements.
In a recent double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the kees, the study provides the evidence in support of the potential efficacy and safety of 5-Loxin in patients with OA. It as proved that 5-Loxin significantly improved joint function and exhibited better therapeutic efficacy at 250 mg/day than at 100 mg/day; it was shown to alleviate pain rapidly, as early as after 1 week of treatment; it reduces levels of the cartilage degrading enzyme MMP-3 in synovial fluid; and, most importantly, 5-Loxin has been considered safe for human consumption, even for the long term use. This study provides important information about the efficacy and safety of 5-Loxin in the treatment of OA, which may be useful in promoting 5-Loxin as a promising alternative therapeutic strategy that has been so justifiably used in Osteo Bi-flex to restore joint health.